Odyssey Therapeutics Inc. (ODTX)
NASDAQ: ODTXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
ODTX stock chart
Technical analysisKey statistics
All statistics- Market cap
- $868.90M
- EPS (TTM)
- -$7.55
- Dividend yield
- None
- 52-week range
- 15.10 – 29.05
- Day range
- 17.83 – 18.84
- Volume / Avg
- 264.07K / 271.02K
- Beta
- —
- Shares outstanding
- 48.06M
- Next earnings
- Nov 4, 2026
52-week range
ODTX stock today
Odyssey Therapeutics (ODTX) closed at $18.08 on Oct 7, down 0.28% (-$0.05), versus the S&P 500's 0.22% decline. Shares are 37.8% below their 52-week high of $29.05, set on Sep 4, 2026 and 19.7% above the 52-week low of $15.10, in the middle of the past year's range. Odyssey Therapeutics has posted a net loss over the last twelve months (EPS of -$7.55), so its P/E ratio is not meaningful.
Odyssey Therapeutics's next earnings report is expected on Nov 4, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Odyssey Therapeutics
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Headquarters
- Boston, MA
- IPO year
- 2026
Earnings
Earnings history- Next report
- Nov 4, 2026
- EPS estimate
- $-1.20
Odyssey Therapeutics peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| GLUEMonte Rosa Therapeutics Inc. | 10.17 | +3.04% | $867.64M | vs ODTX |
| SLBTSL Science Holding Limited | 1.51 | -0.66% | $846.75M | vs ODTX |
| SANASana Biotechnology Inc. | 2.72 | -1.09% | $814.26M | vs ODTX |
| CGEMCullinan Therapeutics Inc. | 15.63 | -3.82% | $960.59M | vs ODTX |
| DNAGinkgo Bioworks Holdings Inc. Class A | 11.47 | -7.57% | $772.39M | vs ODTX |
| CADLCandel Therapeutics Inc. | 9.82 | -0.51% | $751.41M | vs ODTX |
| ATTOAttovia Therapeutics Inc. | 16.42 | -6.17% | $749.59M | vs ODTX |
| SLDBSolid Biosciences Inc. | 6.85 | -1.01% | $734.49M | vs ODTX |
Indexes, lists and sector
Odyssey Therapeutics stock FAQ
What is Odyssey Therapeutics's stock price today?
ODTX last traded at $18.08 as of Oct 7, 4:00 PM EDT, down 0.28% on the day. Prices are delayed at least 15 minutes.
When is Odyssey Therapeutics's next earnings date?
Odyssey Therapeutics is expected to report earnings on Wednesday, November 4, 2026. Analysts expect EPS of $-1.20.
What is the ODTX 52-week high?
The 52-week high for ODTX is $29.05 and the 52-week low is $15.10. The stock is currently 37.8% below its high.